Biological process |
GO:0060333 |
Interferon-gamma-mediated signaling pathway |
1.45 × 10–4
|
HLA-DRB1, HLA-C, HLA-B, HLA-DRA, GBP1 |
18.48 |
GO:0098532 |
Histone H3-K27 trimethylation |
2.06 × 10−4
|
HIST1H1E, HIST1H1D, HIST1H1C |
131.19 |
GO:0016584 |
Nucleosome positioning |
3.82 × 10−4
|
HIST1H1E, HIST1H1D, HIST1H1C |
98.39 |
GO:0006334 |
Nucleosome assembly |
1.03 × 10−3
|
H1F0, HIST1H1E, HMGB2, HIST1H1D, IST1H1C |
11.02 |
GO:0019882 |
Antigen processing and presentation |
1.14 × 10−3
|
HLA-DRB1, HLA-C, HLA-B, HLA-DRA |
19.09 |
GO:0080182 |
Histone H3-K4 trimethylation |
1.41 × 10−3
|
HIST1H1E, HIST1H1D, HIST1H1C |
52.48 |
GO:0002437 |
Inflammatory response to antigenic stimulus |
1.41 × 10−3
|
HMGB1, HMGB2, HLA-DRB1 |
52.48 |
GO:0006309 |
Apoptotic DNA fragmentation |
1.41 × 10−3
|
H1F0, HMGB1, HMGB2 |
52.48 |
GO:0060337 |
Type I interferon signaling pathway |
1.78 × 10−3
|
IFIT1, HLA-C, HLA-B, ISG20 |
16.40 |
GO:0051607 |
Defense response to virus |
3.41 × 10−3
|
AZU1, IFIT1, DEFA3, ISG20, GBP1 |
7.96 |
Molecular function |
GO:0032395 |
MHC class II receptor activity |
1.98 × 10−5
|
KRT17, HLA-DRB1, HLA-C, HLA-DRA |
72.61 |
GO:0042605 |
Peptide antigen binding |
1.38 × 10−4
|
HLA-DRB1, HLA-C, HLA-B, HLA-DRA |
38.90 |
GO:0005198 |
Structural molecule activity |
2.62 × 10−3
|
KRT6C, PGM5, KRT17, FLG, SPRR1B, KRT1, SPRR3 |
7.72 |
GO:0000400 |
Four-way junction DNA binding |
1.14 × 10−3
|
HMGB1, MSH6, HMGB2 |
58.34 |
GO:0031490 |
Chromatin DNA binding |
1.20 × 10−3
|
H1F0, HIST1H1E, HIST1H1D, HIST1H1C |
18.78 |
GO:0003684 |
Damaged DNA binding |
1.53 × 10−3
|
HMGB1, MSH6, HMGB2, MSH5 |
17.29 |
GO:0046977 |
TAP binding |
1.08 × 10−2
|
HLA-C, HLA-B |
181.52 |
GO:097100 |
Supercoiled DNA binding |
1.44 × 10−2
|
HMGB1, HMGB2 |
136.14 |
GO:0044822 |
Poly(A) RNA binding |
1.94 × 10−2
|
H1F0, HMGB1, HIST1H1E, HMGB2, HIST1H1D, HIST1H1C, TRA2B, RPL26, TMSB4X, MANF |
2.41 |
GO:0003725 |
Double-stranded RNA binding |
2.05 × 10−2
|
HMGB1, YRDC, TUBB4B |
13.39 |